Clinical trial
A Study of the Effectiveness and Safety of Almotriptan Versus Placebo in the…
NCT00210509 · Janssen-Ortho LLC, Industry · Completed
Key facts
| NCT number | NCT00210509 |
|---|---|
| Title | A Study of the Effectiveness and Safety of Almotriptan Versus Placebo in the Treatment of Migraine Headache |
| Official title | AXERT® Early miGraine Intervention Study (AEGIS): Efficacy and Safety of Almotriptan Malate (AXERT®) Versus Placebo for the Acute Treatment of Migraine Headache |
| Lead sponsor | Janssen-Ortho LLC, Industry |
| Collaborators | Ortho-McNeil Neurologics, Inc. Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Migraine |
| Intervention type | Drug |
| Interventions | almotriptan malate |
| Enrollment | 378 |
| Start date | Nov 1, 2004 |
| Completion | Jun 1, 2005 |
| First posted | Sep 21, 2005 |
| Last update posted | May 17, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: